Hypercalcemia
📧 Sign up to get email alerts when something new happens for Hypercalcemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-04FDA Approved: CALCITONIN SALMON — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves Zydus Pharmaceuticals USA Inc.'s Original Application for Calcitonin Salmon, a generic version of the established drug. This ap…
-
EMA approval · 2026-02-24EMA Authorised: Zoledronic Acid Accord (zoledronic acid monohydrate) — Accord Healthcare S.L.U.
The EMA authorised Zoledronic Acid Accord (zoledronic acid monohydrate) for hypercalcemia, prevention of fractures in bone disorders, and ca…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]
This completed clinical trial evaluates near-infrared autofluorescence for identifying parathyroid glands during parathyroidectomy, with res…
-
EMA approval · 2025-10-07EMA Authorised: Cinacalcet Viatris (previously Cinacalcet Mylan) (cinacalcet hydrochloride) — Mylan Pharmaceuticals Limited
EMA authorised Cinacalcet Viatris (cinacalcet hydrochloride) for secondary hyperparathyroidism and hypercalcemia, with Mylan Pharmaceuticals…
-
FDA approval · 2025-09-26FDA Approved: CALCITONIN SALMON — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' original application for Calcitonin Salmon (generic), marking the entry of a generic calcitonin product…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]
The clinical trial evaluating near-infrared autofluorescence to identify parathyroid glands during parathyroidectomy has completed, and resu…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating cinacalcet for treating hypercalcemia and secondary hyperparathyroidism in renal transplant recipients…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Hypercalcemia After Paraffin Oil Injection
A clinical trial investigating hypercalcemia after paraffin oil injection is currently recruiting, sponsored by Martin Blomberg Jensen. The …
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Causes, Characteristics and Treatment of Hypercalcemia in the Emergency Room of a German Hospital
An Active-Not-Recruiting clinical trial from the University of Cologne exploring causes, characteristics, and treatment of hypercalcemia pre…
-
FDA approval · 2024-12-05FDA Approved: CALCITONIN SALMON — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's Calcitonin Salmon as an original application (ANDA 212675), enabling the marketing of this generic ca…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
Clinical trial update exploring the pathogenesis and treatment of hypercalcemia caused by intramuscular injection of paraffinoil. The study …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity [Phase 4]
Phase 4 trial update examining calcitonin pretreatment to improve SPECT-CT sensitivity in patients with primary hyperparathyroidism and hype…
-
EMA approval · 2024-09-16EMA Authorised: Bondronat (ibandronic acid) — Atnahs Pharma Netherlands B.V.
EU marketing authorisation granted to Bondronat (ibandronic acid) for hypercalcemia, breast cancer with bone metastases, and bone-related fr…
-
EMA approval · 2024-08-30EMA Authorised: Iasibon (ibandronic acid) — Pharmathen S.A.
EMA authorised Iasibon (ibandronic acid) for hypercalcemia, prevention of bone fractures, and cancer-related indications involving metastati…
-
EMA approval · 2024-06-06EMA Authorised: Mimpara (cinacalcet hydrochloride) — Amgen Europe B.V.
The European Medicines Agency authorised Mimpara (cinacalcet hydrochloride) for indications including hypercalcemia, parathyroid neoplasms, …
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy [NA]
A completed clinical trial evaluated the impact of near-infrared auto-fluorescence (NIRAF) detection for identifying parathyroid glands duri…
-
FDA approval · 2024-04-11FDA Approved: CALCITONIN SALMON — Original Application (Dr. Reddy's Laboratories, Inc.)
FDA approved the original application for Calcitonin Salmon from Dr. Reddy's Laboratories, Inc., enabling the generic to enter the market.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol [Phase 4]
Phase 4 trial comparing calcitriol versus paricalcitol for management of mineral and bone disorders in hemodialysis, terminated with posted …
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Studies of Elevated Parathyroid Activity [Phase 2]
Phase 2 clinical trial updates on studies of elevated parathyroid activity completed; results posted.
-
FDA approval · 2022-01-27FDA Approved: FUROSEMIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved an original generic application for furosemide from Meitheal Pharmaceuticals Inc.
-
FDA approval · 2021-11-10FDA Approved: CALCITONIN SALMON — Original Application (Par Health USA, LLC)
The FDA approved Par Health USA's generic Calcitonin Salmon under ANDA 209358.
-
EMA approval · 2021-11-09EMA Authorised: Zoledronic Acid Hospira (zoledronic acid monohydrate) — Pfizer Europe MA EEIG
EU authorises Zoledronic Acid Hospira (zoledronic acid monohydrate) for hypercalcemia.
-
FDA approval · 2021-05-14FDA Approved: CALCITONIN SALMON — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original application for a generic Calcitonin Salmon product (ANDA 212416).
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cinacalcet to Treat Familial Primary Hyperparathyroidism [Phase 3]
Phase 3 trial evaluating cinacalcet for familial primary hyperparathyroidism with hypercalcemia has been completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism [Phase 3]
Phase 3 intra-individual titration trial evaluating KRN1493 for treating hypercalcemia in patients with parathyroid carcinoma or intractable…